Zsolt Harsanyi, Director at Emergent BioSolutions Inc. (EBS), sold 14,296 shares at $15.07 ($215K) on 2009-07-30, disclosed to the SEC on 2009-08-03.
Scheduled sale ($215k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 596 | $9K | 4.2% |
| 2 | $15.01 | 1,485 | $22K | 10.4% |
| 3 | $15.03 | 105 | $2K | 0.7% |
| 4 | $15.04 | 1,820 | $27K | 12.7% |
| 5 | $15.04 | 80 | $1K | 0.6% |
| 6 | $15.05 | 235 |
| $4K |
| 1.6% |
| 7 | $15.06 | 7,770 | $117K | 54.4% |
| 8 | $15.06 | 620 | $9K | 4.3% |
| 9 | $15.07 | 1,560 | $24K | 10.9% |
| 10 | $15.07 | 25 | $377 | 0.2% |
| Total | $15.05 avg | 14,296 | $215K | 100% |
| Filing → |
| EBS | SELL | 2020-03-17 | $416K | — | Filing → |
| EBS | SELL | 2020-01-17 | $189K | — | Filing → |
| APVO | BUY | 2019-06-07 | $39K | — | Filing → |